Harvard Bioscience Announces First Quarter 2026 Financial Results

Go back to Harvard Bioscience Announces First Quarter 2026 Financial Results
Harvard Bioscience, Inc. (NASDAQ: HBIO) Delayed: 6.47 +0.28 (4.52%)
Previous Close $6.19    52 Week High $3.90 
Open $6.15    52 Week Low $2.25 
Day High $6.49    P/E N/A 
Day Low $6.15    EPS $-0.03 
Volume 13,965